TP53 and neoplasm: To this aim, we inhibited oxytocin signaling by using the L‐368,899 OTR antagonist,22 and investigated the consequent effects of altered mother‐newborn relationship on survival, tumor incidence and spectrum of cancer in the p53 deleted tumor‐prone mouse model.23